Paper26317465
DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts.
Roulois D and 11 others. Cell, 2015. Cited by 1,247 papers, by iCite.
Cite this record
ConductScience Library. DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts. Papers, record 26317465. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26317465
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimetabolites, Antineoplastic | Major topic |
| Azacitidine | Major topic |
| Colorectal Neoplasms | Major topic |
| Adaptor Proteins, Signal Transducing | |
| Animals | |
| Cells, Cultured | |
| DEAD-box RNA Helicases | |
| DNA Methylation | |
| Decitabine | |
| Endogenous Retroviruses | |
| Humans | |
| Interferon Regulatory Factor-7 | |
| Interferon-Induced Helicase, IFIH1 | |
| Mice | |
| RNA, Double-Stranded | |
| Receptors, Retinoic Acid | |
| Signal Transduction |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA082422 | NCI NIH HHS | United States | R01CA082422 | PubMed and NIH | NIH RePORTER |
| R01 CA170550 | NCI NIH HHS | United States | R01CA170550 | PubMed and NIH | NIH RePORTER |
| 5R01CA082422 | NCI NIH HHS | United States | R01CA082422 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 26317460 | DNA Methylation Inhibitors in Cancer Therapy: The Immunity Dimension. | https://conductscience.org/library/papers/26317460 |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10570189 | Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10570189 | PubMed |
| 2 | 14722233 | Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine. | Mol Pharmacol | 2004 | https://conductscience.org/library/papers/14722233 | PubMed |
| 3 | 16125763 | Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. | Cell | 2005 | https://conductscience.org/library/papers/16125763 | PubMed |
| 4 | 16641297 | Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. | J Virol | 2006 | https://conductscience.org/library/papers/16641297 | PubMed |
| 5 | 17122771 | Identification and expansion of human colon-cancer-initiating cells. | Nature | 2007 | https://conductscience.org/library/papers/17122771 | PubMed |
| 6 | 24583822 | Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers. | Oncotarget | 2014 | https://conductscience.org/library/papers/24583822 | PubMed |
| 7 | 24952503 | Diverse intracellular pathogens activate type III interferon expression from peroxisomes. | Nat Immunol | 2014 | https://conductscience.org/library/papers/24952503 | PubMed |
| 8 | 25263941 | Gene body methylation can alter gene expression and is a therapeutic target in cancer. | Cancer Cell | 2014 | https://conductscience.org/library/papers/25263941 | PubMed |
| 9 | 25012502 | RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8(+) T cells. | Cell Death Differ | 2014 | https://conductscience.org/library/papers/25012502 | PubMed |
| 10 | 25525240 | RETRACTED: MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses. | Science | 2014 | https://conductscience.org/library/papers/25525240 | PubMed |
| 11 | 17122772 | A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. | Nature | 2007 | https://conductscience.org/library/papers/17122772 | PubMed |
| 12 | 17548814 | Phenotypic characterization of human colorectal cancer stem cells. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17548814 | PubMed |
| 13 | 18591409 | Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. | J Exp Med | 2008 | https://conductscience.org/library/papers/18591409 | PubMed |
| 14 | 19066511 | Screening for amyloid aggregation by Semi-Denaturing Detergent-Agarose Gel Electrophoresis. | J Vis Exp | 2008 | https://conductscience.org/library/papers/19066511 | PubMed |
| 15 | 19509174 | Targeting DNA methylation. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19509174 | PubMed |
| 16 | 19567251 | ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. | J Immunol Methods | 2009 | https://conductscience.org/library/papers/19567251 | PubMed |
| 17 | 21224412 | RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21224412 | PubMed |
| 18 | 21219183 | Nucleic acid recognition by the innate immune system. | Annu Rev Immunol | 2011 | https://conductscience.org/library/papers/21219183 | PubMed |
| 19 | 21419747 | The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. | Cell Stem Cell | 2011 | https://conductscience.org/library/papers/21419747 | PubMed |
| 20 | 21782231 | MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. | Cell | 2011 | https://conductscience.org/library/papers/21782231 | PubMed |
Cited by982
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,247 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42988922 | Repurposed endogenous virus-like vesicles mediate dendritic cell long-range antigen presentation and T cell activation for enhanced cancer vaccination. | Nat Nanotechnol | 2026 | https://conductscience.org/library/papers/42988922 | PubMed |
| 42977802 | Intratumoral co-activation of ERV transcription and RNA virus-sensing is associated with radiotherapy-induced immune response and abscopal effect. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/42977802 | PubMed |
| 42955439 | Treatment options after tumor resistance: exploiting vulnerabilities from genome to tumor microenvironment. | Cancer Metastasis Rev | 2026 | https://conductscience.org/library/papers/42955439 | PubMed |
| 42951312 | Epigenetic repression of oncogenic signaling defines immune-permissive tumor states associated with response to immune checkpoint inhibitors in advanced NSCLC. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42951312 | PubMed |
| 42948523 | The immunogenicity control axis: a multi-omics framework for integrating epigenetic, DNA damage response, and immune states in cancer. | Front Genet | 2026 | https://conductscience.org/library/papers/42948523 | PubMed |
| 42947156 | Cancer therapy resistance converges on immune evasion: a unified framework from immunotherapy to targeted, endocrine, and DNA repair pathways. | J Exp Clin Cancer Res | 2026 | https://conductscience.org/library/papers/42947156 | PubMed |
| 42944072 | From Defenders to Hosts: The Arm-in-Arm Expansion of KRAB-Zinc Finger Gene Repertoires and Retroviral Integrations in Mammals. | Viruses | 2026 | https://conductscience.org/library/papers/42944072 | PubMed |
| 42925407 | Decitabine and azacitidine exert multifaceted effects beyond DNA hypomethylation in myeloid neoplasms. | Int J Hematol | 2026 | https://conductscience.org/library/papers/42925407 | PubMed |
| 42920669 | The "mobile bricks" of human evolution: how transposable elements shaped human phenotypes. | Front Genet | 2026 | https://conductscience.org/library/papers/42920669 | PubMed |
| 42913692 | Cancer Cell CD73 Loss Promotes a Dual Inflammatory and Immunosuppressive Microenvironment in Endometrial Carcinoma. | Cancer Res Commun | 2026 | https://conductscience.org/library/papers/42913692 | PubMed |
| 42895683 | Epigenetics in development, disease, and therapy: from mechanisms to clinical interventions. | Sci China Life Sci | 2026 | https://conductscience.org/library/papers/42895683 | PubMed |
| 42888182 | Transposable elements, immune-related genes and epigenetic context in teleost fish: insights from a systematic review and in silico analysis. | Heredity (Edinb) | 2026 | https://conductscience.org/library/papers/42888182 | PubMed |
| 42834519 | MAJEC: unified gene, isoform, and locus-level transposable element quantification from RNA-seq. | Bioinformatics | 2026 | https://conductscience.org/library/papers/42834519 | PubMed |
| 42829586 | Transposable Element Dysregulation in Hepatocellular Carcinoma: Epigenetic Mechanisms, Immune Remodeling, and Translational Opportunities. | J Hepatocell Carcinoma | 2026 | https://conductscience.org/library/papers/42829586 | PubMed |
| 42829380 | The therapeutic potential of transposable element activity modulation. | EMBO Mol Med | 2026 | https://conductscience.org/library/papers/42829380 | PubMed |
| 42819755 | The inflammation-epigenetics axis in gastric cancer: Helicobacter-driven field defects, immune escape, and therapeutic frontiers. | Front Immunol | 2026 | https://conductscience.org/library/papers/42819755 | PubMed |
| 42802274 | Triptolide sensitizes cancer cells to nucleoside DNA methyltransferase inhibitors through inhibition of DCTPP1-mediated cell-intrinsic resistance. | Nat Commun | 2026 | https://conductscience.org/library/papers/42802274 | PubMed |
| 42792545 | Mechanisms of Immune Cell Dysregulation in Pancreatic Ductal Adenocarcinoma. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42792545 | PubMed |
| 42781243 | Targeting the DNA Damage Response in Cancer. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42781243 | PubMed |
| 42774118 | Clinical activity of chidamide-containing regimens after prior PD-1-based therapy in two patients with microsatellite-stable metastatic colorectal cancer: a case series and narrative review. | Front Oncol | 2026 | https://conductscience.org/library/papers/42774118 | PubMed |
Genes21
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GEO | GSE62086 |
Source GEO
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26317465
GET https://conductscience.org/api/papers/v1/26317465/references?page=2